EGFR and colorectal carcinoma: However, some studies have shown that anti-EGFR based therapy may not be effective in treating mCRC, indicating that a subset of CRC is resistant to the anti-EGFR treatment (Bokemeyer et al., 2009; Van Cutsem et al., 2009).